Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Prevalence and Location of White Matter Hyperintensities in Traumatic Brain Injury and Relationship to Outcome
Aging and Dementia
S15 - Aging and Dementia 1 (4:18 PM-4:30 PM)
005

Although WMHs are commonly seen after TBI, little is known about their relationship with pathology and long-term outcomes. We hypothesized that distinctions exist between the prevalence and location of WMHs in TBI participants compared with healthy controls, and are related to outcomes after TBI.

To assess the prevalence and location of white matter hyperintensities (WMH), and their link to clinical outcomes, among patients with traumatic brain injury (TBI).

Participants with TBI were studied at 2 weeks and 6 months post-injury. Healthy controls were also enrolled. WMHs were manually segmented then using tools available in FreeSurfer, were categorized into periventricular (adjacent to a ventricle), subcortical (>4mm from the gray-white junction), or juxtacortical (<4mm from the gray-white junction).

Thirty-five participants with TBI (mean[SD] age: 44.7[16.6], 74% male, median GCS: 15 (IQR:14-15)) and 15 control subjects (mean[SD] age: 33.2[11.8], 60% male) were enrolled. TBI patients had a significantly higher burden of WMHs at 2 weeks (20.8±25.3) compared with controls (5.27±4.2; p=0.023). When TBI participants were re-scanned 6 months later, the number of WMHs over time did not change (21.38+33.29, p=0.24). The large majority of WMH were found in the juxtacortical area (controls: 49.4% vs. TBI at 2 weeks: 67.4% (p=0.02); TBI at 6 months: 66.8% (p=0.05)). There was no relationship between WMH burden and functional outcome, assessed by Glasgow Outcome Scale-Extended. There was a significant relationship between WMH burden at 2 weeks and the cognitive component of the Rivermead Post-Concussion Symptom Questionnaire at 2 weeks (r=-0.414, p=0.021).

WMHs are common after predominantly mild TBI and are more prevalent than age- and gender-matched healthy controls. WMHs are primarily juxtacortical, a distribution distinct from what is found in demyelinating disease and aging. While non-specific, WMHs are common in TBI, and in appropriate clinical settings may be helpful diagnostically and prognostically.

Authors/Disclosures
Abbie Chan
PRESENTER
Miss Chan has nothing to disclose.
No disclosure on file
James J. Gugger, Jr., MD, PharmD (University of Pennsylvania) Dr. Gugger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. The institution of Dr. Gugger has received research support from American Epilepsy Society.
No disclosure on file
No disclosure on file
No disclosure on file
Ramon R. Diaz-Arrastia, MD, PhD, FAAN (University of Pennsylvania) Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ischemix, Inc. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pinteon Therapeutics. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from NovaSignal . Dr. Diaz-Arrastia has received stock or an ownership interest from Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.